| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.007 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |